Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT02770586 Completed - Breast Cancer Clinical Trials

Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI

PEM/MRI
Start date: August 2015
Phase: N/A
Study type: Interventional

The hypothesis of this study is that positron emission mammography will provide comparable sensitivity to contrast-enhanced breast MRI in women with a high suspicion of breast cancer. The aim of this study is to determine the sensitivity of Positron Emission Mammography (PEM) relative to that of Contrast-enhanced breast MRI (CE-MRI) in women with a high suspicion of breast cancer

NCT ID: NCT02770469 Completed - Breast Cancer Clinical Trials

Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer Survivors

TOGETHER
Start date: February 2014
Phase: N/A
Study type: Interventional

The objective of the TOGETHER (Together Overcome and Get Empowered Through Health Education and Relationships) program was to examine the effectiveness of one of the first linguistically and culturally tailored intervention programs to increase quality of life among Korean American breast cancer survivors.

NCT ID: NCT02769364 Completed - Breast Cancer Clinical Trials

Extended Treatment in Metastatic Breast Cancer With Eribulin

EXTER
Start date: November 2013
Phase:
Study type: Observational

Decision-making for treatment of metastatic breast cancer after the second line of chemotherapy was limited by the lack of established predictive factors of benefit for further chemotherapy regimens. Eribulin has emerged as the only single agent demonstrating an overall survival improvement in the third-line setting or beyond. The purpose of this study was to define the clinical profile of metastatic breast cancer participants achieving long-term benefit from chemotherapy with eribulin in the third-line setting or beyond.

NCT ID: NCT02769299 Completed - Breast Cancer Clinical Trials

Cardiotoxicity of Radiation Therapy (CTRT)

Start date: June 2, 2015
Phase:
Study type: Observational

The overall objective of this proposal is to determine the utility of sensitive imaging and biomarker measures in detecting subclinical cardiotoxicity across a spectrum of radiation doses to the heart. We will focus specifically on patients receiving photon or proton chest radiotherapy. Our broad working hypothesis is that RT induces early, subclinical CV injury, as evidenced by cardiomyocyte inflammation and necrosis, and worsening CV function.

NCT ID: NCT02767986 Completed - Breast Cancer Clinical Trials

Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance

Start date: May 10, 2016
Phase:
Study type: Observational

Background: Culture can affect the way a person thinks about illness. This can affect how they seek help for illness. It can also affect how they choose a treatment and follow it. This can lead to health disparities among certain groups of people. Breast and colon cancers are the most common cancers for Latinos. Even though they get these cancers at lower rates than other population groups, Latinos are more likely to be diagnosed with these cancers at advanced stages. Researchers want to study what Latina women immigrants believe causes breast and colon cancer and other factors they think play a role in disease. This understanding could lead to better interactions between Latinos and their doctors. Objective: To learn more about what Latina immigrants believe causes breast and colon cancer and other factors they think play a role in disease. Eligibility: Women ages 18 and older who: Were born in Latin America Speak Spanish Have never had breast, ovarian, or colon cancer Design: Participants will be interviewed in person or over the phone. This will take up to an hour. The interview will be recorded. Participants will answer questions about: Their family s cancer history What they think causes breast and colon cancer What they think plays a role in disease ...

NCT ID: NCT02763228 Completed - Breast Cancer Clinical Trials

Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors

Start date: March 16, 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine whether a physical activity (exercise) program in the community will improve the functional and overall health status of older women with a history of breast cancer. The physical activity or exercise program is designed for all older breast cancer survivors, and in particular for African-Americans and women of lower socio-economic status, who are the least likely to engage in physical activity.

NCT ID: NCT02761616 Completed - Breast Cancer Clinical Trials

A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

Start date: June 2016
Phase: N/A
Study type: Observational

This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.

NCT ID: NCT02759796 Completed - Breast Cancer Clinical Trials

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Start date: November 2015
Phase: N/A
Study type: Interventional

It is a single-center, prospective, randomized and controlled study focused in microsurgical autologous breast reconstruction. It involves applying indocyanine green (ICG) angiography for the study of the vascularization of DIEP flaps. The aim of the study is to determine whether there are differences in complications and aesthetic results when ICG is used to discard the poorly vascularized areas of the flap. The study includes adult women undergoing unilateral DIEP flap breast reconstruction. The calculated sample size is 60 patients. There are two groups. In group 1, the investigators use the usual clinical criteria to discard the poorly vascularized areas of the flap. In group 2, the investigators use the ICG to shape the flap.

NCT ID: NCT02759133 Completed - Breast Cancer Clinical Trials

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire

IodineBreast
Start date: June 2016
Phase: N/A
Study type: Interventional

This is a monocentric, non-inferiority, randomized cohort study with an open 1:1 ratio comparing the impact of iodine seed tumor localization (arm B) vs. standard localization using a metal guide (arm A) on the quality of the surgical resection margins in parallel groups with an interim analysis in patients with breast cancer. Randomization will be performed using histologic status stratification: in situ ductal /invasive lobular +/- an in situ component / invasive ductal +/- an in situ component.

NCT ID: NCT02758249 Completed - Breast Cancer Clinical Trials

Anesthetic Effect on Immune Cell in Patients With Cancer

Start date: January 2016
Phase: N/A
Study type: Interventional

Anesthetics agents has an effect on immune response during the cancer surgery.This influence can regulatory to immune activity or cancer cell survival. The purpose of this study is to prove the variation of immune cell activity between preoperative and postoperative period.